Smoking water-pipe, chewing nass and prevalence of heart disease: A cross-sectional analysis of baseline data from the Golestan Cohort Study, Iran

Heart

Volumn 99, Issue 4, 2013, Pages 272-278

  Islami, Farhad ^a,b   Pourshams, Akram ^a   Vedanthan, Rajesh ^b   Poustchi, Hossein ^a   Kamangar, Farin ^c,d   Golozar, Asieh ^a,d   Etemadi, Arash ^a,d   Khademi, Hooman ^a,e   Freedman, Neal D ^d   Merat, Shahin ^a   Garg, Vaani ^b   Fuster, Valentin ^b,f   Wakefield, Jon ^g   Dawsey, Sanford M ^d   Pharoah, Paul ^h   Brennan, Paul ^e   Abnet, Christian C ^d   Malekzadeh, Reza ^a   Boffetta, Paolo ^b,i  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c MORGAN STATE UNIVERSITY   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^f CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^g UNIVERSITY OF WASHINGTON   (United States)

^h UNIVERSITY OF CAMBRIDGE   (United Kingdom)

ⁱ INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHEWING NASS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; FEMALE; HEART DISEASE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SMOKING; SMOKING AND SMOKING RELATED PHENOMENA; SMOKING HABIT; SMOKING WATER PIPE;

ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HEART DISEASES; HUMANS; IRAN; MALE; MASTICATION; MIDDLE AGED; PLANT EXTRACTS; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING; TOBACCO; TOBACCO, SMOKELESS;

EID: 84873087826     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2012-302861     Document Type: Article

References (52)

1. World Health Organization. Preventing chronic diseases: a vital investment: WHO global report. Geneva: WHO Press, 2005.
2. Abegunde DO, Mathers CD, Adam T, et al. The burden and costs of chronic diseases in low-income and middle-income countries. Lancet 2007;370:1929-38.
3. Hammond EC, Horn D. Smoking and death rates; report on forty-four monghs of follow-up of 187, 783 men. II. Death rates by cause. J Am Med Assoc 1958;166:1294-308.
4. Ezzati M, Lopez AD. Measuring the accumulated hazards of smoking: global and regional estimates for 2000. Tob Control 2003;12:79-85.
5. He J, Ogden LG, Bazzano LA, et al. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med 2001;161:996-1002.
6. Butler J, Kalogeropoulos A, Georgiopoulou V, et al. Incident heart failure prediction in the elderly: the health ABC heart failure score. Circ Heart Fail 2008;1:125-33.
7. Djousse L, Driver JA, Gaziano JM. Relation between modifiable lifestyle factors and lifetime risk of heart failure. JAMA 2009;302:394-400.
8. Wang Y, Tuomilehto J, Jousilahti P, et al. Lifestyle factors in relation to heart failure among Finnish men and women. Circ Heart Fail 2011;4:607-12.
9. Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat Rev Cardiol 2011;8:30-41.
10. Maziak W. The global epidemic of waterpipe smoking. Addict Behav 2011;36:1-5.
11. Eissenberg T, Shihadeh A. Waterpipe tobacco and cigarette smoking: direct comparison of toxicant exposure. Am J Prev Med 2009;37:518-23.
12. Monzer B, Sepetdjian E, Saliba N, et al. Charcoal emissions as a source of CO and carcinogenic PAH in mainstream narghile waterpipe smoke. Food Chem Toxicol 2008;46:2991-5.
13. Ghasemi A, Syedmoradi L, Momenan AA, et al. The influence of cigarette and qalyan (hookah) smoking on serum nitric oxide metabolite concentration. Scand J Clin Lab Invest 2010;70:116-21.
14. Ward KD, Hammal F, VanderWeg MW, et al. Are waterpipe users interested in quitting? Nicotine Tob Res 2005;7:149-56.
15. Jackson D, Aveyard P. Waterpipe smoking in students: prevalence, risk factors, symptoms of addiction, and smoke intake. Evidence from one British university. BMC Public Health 2008;8:174.
16. Warren CW, Lea V, Lee J, et al. Change in tobacco use among 13-15-year-olds between 1999 and 2008: findings from the Global Youth Tobacco Survey. Glob Health Promot 2009;16:38-90.
17. Grekin ER, Ayna D. Waterpipe smoking among college students in the United States: a review of the literature. J Am Coll Health 2012;60:244-9.
18. Gatrad R, Gatrad A, Sheikh A. Hookah smoking. BMJ 2007;335:20.
19. Boffetta P, Straif K. Use of smokeless tobacco and risk of myocardial infarction and stroke: systematic review with meta-analysis. BMJ 2009;339:b3060.
20. Teo KK, Ounpuu S, Hawken S, et al. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet 2006;368:647-58.
21. Piano MR, Benowitz NL, Fitzgerald GA, et al. Impact of smokeless tobacco products on cardiovascular disease: implications for policy, prevention, and treatment: a policy statement from the American Heart Association. Circulation 2010;122:1520-44.
22. Arefalk G, Hergens MP, Ingelsson E, et al. Smokeless tobacco (snus) and risk of heart failure: results from two Swedish cohorts. Eur J Prev Cardiol 2012;19:1120-7.
23. Pourshams A, Khademi H, Malekshah AF, et al. Cohort Profile: The Golestan Cohort Study-a prospective study of oesophageal cancer in northern Iran. Int J Epidemiol 2010;39:52-9.
24. Islami F, Kamangar F, Nasrollahzadeh D, et al. Socio-economic status and oesophageal cancer: results from a population-based case-control study in a high-risk area. Int J Epidemiol 2009;38:978-88.
25. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-52.
26. Wilson PW. Risk scores for prediction of coronary heart disease: an update. Endocrinol Metab Clin North Am 2009;38:33-44.
27. D'Agostino RB Sr., Grundy S, Sullivan LM, et al. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001;286:180-7.
28. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004;110:227-39.
29. Jabbour S, El-Roueiheb Z, Sibai AM. Nargileh (Water-Pipe) smoking and incident coronary heart disease: a case-control study. Ann Epidemiol 2003;13:570.
30. Akl EA, Gaddam S, Gunukula SK, et al. The effects of waterpipe tobacco smoking on health outcomes: a systematic review. Int J Epidemiol 2010;39:834-57.
31. Raad D, Gaddam S, Schunemann HJ, et al. Effects of water-pipe smoking on lung function: a systematic review and meta-analysis. Chest 2011;139:764-74.
32. Ali AA. Histopathologic changes in oral mucosa of Yemenis addicted to water-pipe and cigarette smoking in addition to takhzeen al-qat. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103:e55-9.
33. Nasrollahzadeh D, Kamangar F, Aghcheli K, et al. Opium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a high-risk area of Iran. Br J Cancer 2008;98:1857-63.
34. Bedwani R, el Khwsky F, Renganathan E, et al. Epidemiology of bladder cancer in Alexandria, Egypt: tobacco smoking. Int J Cancer 1997;73:64-7.
35. Zheng YL, Amr S, Saleh DA, et al. Urinary Bladder Cancer Risk Factors in Egypt: A Multicenter Case-Control Study. Cancer Epidemiol Biomarkers Prev 2012;21:537-46.
36. Okura Y, Urban LH, Mahoney DW, et al. Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol 2004;57:1096-103.
37. Szklo M, Nieto J. Epidemiology: beyond the basics. 2 edn. Sudbury, MA: Jones and Bartlett Publishers, 2007.
38. World Health Organization. WHO Global Infobase. Mortalities, Iran (Islamic Republic of), 2004. https://apps.who.int/infobase/Mortality.aspx (assessed 14 Sep 2012).
39. Sadr Bafghi SM, Beiki Bandarabadi O, Rafiei M, et al. Investigation of clinical and paraclinical characteristics of heart failure in patients admitted in hospitals in Yazd City, 2000-2001. J Shahid Sadoughi Univ Med Sci Health Serv 2007;15:20-8. (In Persian).
40. Garakyaraghi M, Kerdegari M, Siavash M. Calcium and vitamin D status in heart failure patients in Isfahan, Iran. Biol Trace Elem Res 2010;135:67-73.
41. Agarwal AK, Venugopalan P, de Bono D. Prevalence and aetiology of heart failure in an Arab population. Eur J Heart Fail 2001;3:301-5.
42. Ergin A, Eryol NK, Unal S, et al. Epidemiological and pharmacological profile of congestive heart failure at Turkish academic hospitals. Anadolu Kardiyol Derg 2004;4:32-8.
43. Khan H, Jan H, Hafizullah M. A hospital-based study on causes peculiar to heart failure. J Tehran Univ Heart Centr 2009;1:25-8.
44. AlHabib KF, Elasfar AA, AlBackr H, et al. Design and preliminary results of the heart function assessment registry trial in Saudi Arabia (HEARTS) in patients with acute and chronic heart failure. Eur J Heart Fail 2011;13:1178-84.
45. Assiri AS. Clinical and therapeutic profiles of heart failure patients admitted to a Tertiary Hospital, Aseer Region, Saudi Arabia. Sultan Qaboos Univ Med J 2011;11:230-5.
46. Cleland JG, McDonagh T, Rigby AS, et al. The national heart failure audit for England and Wales 2008-2009. Heart 2011;97:876-86.
47. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group. N Engl J Med 1997;336:525-33.
48. Hunt SA. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2005;46:e1-82.
49. Abnet CC, Saadatian-Elahi M, Pourshams A, et al. Reliability and validity of opiate use self-report in a population at high risk for esophageal cancer in Golestan, Iran. Cancer Epidemiol Biomarkers Prev 2004;13:1068-70.
50. Barcin C, Tapan S, Kursaklioglu H, et al. Effects of non-heavy smoking on high-density lipoprotein cholesterol in healthy Turkish young men. Acta Cardiol 2006;61:411-15.
51. Nakamura K, Barzi F, Huxley R, et al. Does cigarette smoking exacerbate the effect of total cholesterol and high-density lipoprotein cholesterol on the risk of cardiovascular diseases? Heart 2009;95:909-16.
52. Wakabayashi I, Groschner K. Age-dependent associations of smoking and drinking with non-high-density lipoprotein cholesterol. Metabolism 2010;59:1074-81.